Page 2 - Managing Advanced Urothelial Carcinoma in 2020: Canadian Consensus Updates
P. 2

Presenter Disclosure



            Aly-Khan Lalani



                                                                        Company/                           Details
                                                                        Organization
              I have received a grant(s) or an honorarium from a        AbbVie, Astellas, BMS, Eisai, Ipsen,   Honoraria
              commercial organization.                                  Janssen, Merck, Novartis, Pfizer,
                                                                        Roche, TerSera, CUA

                                                                        Novartis, Roche, Ipsen, EMD Serrono  Research grants, all funds paid to HHS
              I am currently participating in or have participated in a   BMS, Merck                       All funds paid to HHS
              clinical trial within the past two years.
   1   2   3   4   5   6   7